Actelion sales rise ahead of anticipated drug approval
ZURICH (Reuters) - Actelion, Europe's largest biotech company, confirmed its full-year outlook on Thursday ahead of a widely anticipated approval of i...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/Apy9SrwaQlI/story01.htm
No comments:
Post a Comment